Xtant Medical Reports Third Quarter 2026 Financial Results with Revenue and EPS Miss
Xtant Medical (XTNT) reported third-quarter financial results that fell short of market expectations. The company posted a GAAP earnings per share (EPS) loss of $0.03, missing estimates by $0.01. Total revenue for the quarter reached $24.3 million, representing a 26.9% decline year-over-year and falling $1.18 million below consensus forecasts. The company also reported a significant downturn in profitability metrics. Adjusted EBITDA swung to a loss of $1.5 million for the third quarter of 2026, a sharp reversal from the adjusted EBITDA profit of $4.5 million recorded in the prior year period.

Tickers: $XTNT
Topics: adjusted EBITDA earnings miss GAAP EPS revenue decline
Read the full article at Seeking Alpha
Part of the story Elah Holdings, Inc. Releases Third Quarter 2026 Financial Statements (8 articles)